Jun 22, 2020
Global Market Outlook for the Alternative Non-Nicotine Liquid Vaping Products Market 2020 - Market Analysis of Herbals, Extracts and Vitamin Vaping
Jun 17, 2020
Respira Technologies, Inc. announces plan to pursue FDA authorization for the RespiRxTM drug delivery platform as the first "vapor style" Nicotine Replacement Therapy targeting the 50% of smokers who want to quit
Jun 11, 2020
Global Pandemic of Smoking-related Disease to Kill Seven Million More in 2020: Viable Solutions Blocked by Moral Panics and Big Philanthropy
Apr 30, 2020
Achieve Life Sciences Announces Private Placement of $1.9 Million
Mar 16, 2020
The Global Smoking Cessation and Nicotine De-addiction Market is expected to grow by USD 16.6 bn during 2020-2024, progressing at a CAGR of 13% during the forecast period
Mar 14, 2020
BrainsWay Announces Positive Data from Smoking Cessation Multicenter Study Evaluating Use of Deep TMS at Society for Research on Nicotine & Tobacco 2020
Mar 12, 2020
Achieve Life Sciences Announces Presentation of Additional Cytisinicline Analyses at the Society for Research on Nicotine & Tobacco (SRNT) Annual Meeting
Feb 24, 2020
The Global Smoking Cessation and Nicotine De-Addiction Market is expected to grow by USD 16.6 bn during 2020-2024, progressing at a CAGR of 13% during the forecast period
Feb 04, 2020
Global Smoking Cessation and Nicotine De-Addiction Market to Expand at a CAGR of 4.5% Over 2018 to 2026, Reaching US$ 13.6 Bn by 2026: Transparency Market Research
Jan 22, 2020
Statement from the Council of Chief Medical Officers of Health on Nicotine Vaping in Canada
Jan 13, 2020
Achieve Life Sciences, University of Bristol, and Oracle Corporation Announce Study Results Demonstrating Potential for Accelerated Speed of Drug Discovery
Dec 17, 2019
FDA permits sale of two new reduced nicotine cigarettes through premarket tobacco product application pathway
Dec 09, 2019
Achieve Life Sciences Announces Completion of Meeting with the U.S. Food & Drug Administration (FDA) on Cytisinicline Smoking Cessation Phase 3 Clinical Development Program
Nov 18, 2019
Amygdala Neurosciences Announces $5.6M Financing and Dr. Mack Mitchell's Expanded Role as CMO
Nov 12, 2019
IntelliQuit's Cloud Based Nicotine Bio-Monitoring Measures Nicotine Consumption in Vapers Aiding Treatment
Nov 06, 2019
Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program
Nov 05, 2019
Smokers Offered Fresh Hope With the UK Launch of VOKE
Oct 15, 2019
As Drug Cartels Leverage Vaping Infrastructure, Expect Vaping Deaths to Rise Sharply
Oct 01, 2019
Avoiding the Dangers of Vaping: U.S. E-Cig Patent Holder Offers Patent for Sale to Address Controversy Over Vaping Health Concerns
Sep 30, 2019
Achieve Life Sciences Announces Completion of Maximum Tolerated Dose Study